{"id":"placebo-30-50-or-70-mg","_fda":{"id":"ca7bbcc8-2354-375c-e053-2995a90a72a0","set_id":"0000025c-6dbf-4af7-a741-5cbacaed519a","openfda":{"upc":["8907460005526"],"unii":["ETJ7Z6XBU4"],"route":["ORAL"],"spl_id":["ca7bbcc8-2354-375c-e053-2995a90a72a0"],"brand_name":["SILICEA"],"spl_set_id":["0000025c-6dbf-4af7-a741-5cbacaed519a"],"package_ndc":["15631-0404-0","15631-0404-1","15631-0404-2","15631-0404-3","15631-0404-4","15631-0404-5","15631-0404-6","15631-0404-7"],"product_ndc":["15631-0404"],"generic_name":["SILICEA"],"product_type":["HUMAN OTC DRUG"],"substance_name":["SILICON DIOXIDE"],"manufacturer_name":["Rxhomeo Private Limited d.b.a. Rxhomeo, Inc"],"is_original_packager":[true]},"purpose":["USES USES: Temporary Relief - Acne, Boils* * Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."],"version":"2","stop_use":["If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional."],"warnings":["WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional. As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product. Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use."],"questions":["QUESTIONS OR COMMENTS www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com Rxhomeo, Inc 3200 Commander Dr, Ste 100-W1, Carrollton, TX 75006 USA"],"do_not_use":["Do not use if capseal is broken or missing. Close the cap tightly after use."],"effective_time":"20210902","active_ingredient":["ACTIVE INGREDIENT SILICEA HPUS 2X and higher"],"inactive_ingredient":["INACTIVE INGREDIENTS Sucrose"],"storage_and_handling":["STORAGE Store in a cool dark place"],"indications_and_usage":["INDICATIONS Condition listed above or as directed by the physician"],"dosage_and_administration":["DOSAGE Adults- Take 4 or 6 Pellets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose."],"spl_product_data_elements":["SILICEA SILICEA SUCROSE SILICON DIOXIDE SILICON DIOXIDE"],"pregnancy_or_breast_feeding":["As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product."],"keep_out_of_reach_of_children":["Keep this and all medication out of reach of children"],"package_label_principal_display_panel":["Mini-Label Label-Pellets Blister-Pack Carton-Pack"]},"safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo)"}]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo \"30, 50 or 70 mg\"","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T06:51:26.917595+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T06:51:32.297153+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo \"30, 50 or 70 mg\"","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T06:51:32.472473+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T06:51:25.802545+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T06:51:25.802574+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4108860/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:51:33.529911+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo effects are mediated by psychological expectation and conditioning, which can activate endogenous neurotransmitter systems, reduce pain perception, and modulate immune and autonomic nervous system responses. The effect is particularly pronounced in conditions with subjective symptomatology such as pain, nausea, and anxiety. While placebo contains no active pharmaceutical ingredient, the ritual of treatment and patient belief can produce measurable clinical improvements in certain conditions.","oneSentence":"Placebo produces therapeutic effects through the patient's expectation and belief in treatment, activating endogenous neurobiological pathways independent of pharmacological action.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:00:38.133Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:51:35.748369+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Research and clinical trial control comparator"}]},"trialDetails":[{"nctId":"NCT01071044","phase":"PHASE4","title":"Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome","status":"COMPLETED","sponsor":"Rochester Center for Behavioral Medicine","startDate":"2009-11","conditions":"Chronic Fatigue Syndrome, Cognitive Impairments","enrollment":26},{"nctId":"NCT00500149","phase":"PHASE3","title":"A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Shire","startDate":"2007-06-13","conditions":"ADHD","enrollment":129},{"nctId":"NCT01101022","phase":"PHASE4","title":"Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Shire","startDate":"2010-05-19","conditions":"ADHD Specifically With Executive Function Impairment","enrollment":161},{"nctId":"NCT00697515","phase":"PHASE3","title":"Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Shire","startDate":"2008-07-18","conditions":"ADHD","enrollment":142},{"nctId":"NCT01436162","phase":"PHASE3","title":"Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Shire","startDate":"2011-10-19","conditions":"Major Depressive Disorder","enrollment":1105},{"nctId":"NCT01436149","phase":"PHASE3","title":"Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Shire","startDate":"2011-10-27","conditions":"Major Depressive Disorder","enrollment":1262},{"nctId":"NCT02555150","phase":"PHASE3","title":"A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD","status":"COMPLETED","sponsor":"Rhodes Pharmaceuticals, L.P.","startDate":"2015-09","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":40},{"nctId":"NCT00801229","phase":"PHASE4","title":"Effect of Vyvanse on Driving in Young Adults With ADHD","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-12","conditions":"Attention Deficit/Hyperactivity Disorder(ADHD)","enrollment":75},{"nctId":"NCT00807222","phase":"NA","title":"Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Clinical Study Centers, LLC","startDate":"2008-04","conditions":"Attention Deficit Hyperactivity Disorder, Sleep","enrollment":24}],"_emaApprovals":[],"_faersSignals":[{"count":802300,"reaction":"DRUG INEFFECTIVE"},{"count":530285,"reaction":"OFF LABEL USE"},{"count":518631,"reaction":"NAUSEA"},{"count":504212,"reaction":"FATIGUE"},{"count":438337,"reaction":"DIARRHOEA"},{"count":428633,"reaction":"DEATH"},{"count":399609,"reaction":"HEADACHE"},{"count":384776,"reaction":"PAIN"},{"count":380451,"reaction":"DYSPNOEA"},{"count":331086,"reaction":"DIZZINESS"}],"administration":{"route":"Oral"},"crossReferences":{"chemblId":"CHEMBL4108860"},"_approvalHistory":[{"date":"20150716","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20251222","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20161121","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20150903","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20111201","type":"ORIG","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20140818","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20231215","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20130611","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20191007","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20161216","type":"SUPPL","sponsor":"HOSPIRA INC","applicationNumber":"NDA200403"},{"date":"20161027","type":"ORIG","sponsor":"LUOXIN AUROVITAS","applicationNumber":"ANDA206543"},{"date":"20170525","type":"ORIG","sponsor":"GLENMARK PHARMS LTD","applicationNumber":"ANDA203821"},{"date":"20230920","type":"SUPPL","sponsor":"GLENMARK PHARMS LTD","applicationNumber":"ANDA203821"},{"date":"20220126","type":"SUPPL","sponsor":"GLENMARK PHARMS LTD","applicationNumber":"ANDA203821"},{"date":"20250321","type":"ORIG","sponsor":"ANTHEA PHARMA","applicationNumber":"ANDA219883"},{"date":"19990923","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19891013","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19880510","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19861216","type":"ORIG","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19870609","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"20020625","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"20011102","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"20000320","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19920204","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19970218","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19881117","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19880128","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19870609","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"20100623","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"20130116","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"20020808","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"20020625","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"20000320","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"},{"date":"19960118","type":"SUPPL","sponsor":"ACTAVIS ELIZABETH","applicationNumber":"ANDA070975"}],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Sugar pill"],"phase":"marketed","status":"active","brandName":"Placebo \"30, 50 or 70 mg\"","genericName":"Placebo \"30, 50 or 70 mg\"","companyName":"Rochester Center for Behavioral Medicine","companyId":"rochester-center-for-behavioral-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces therapeutic effects through the patient's expectation and belief in treatment, activating endogenous neurobiological pathways independent of pharmacological action. Used for Research and clinical trial control comparator.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T06:51:35.748369+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}